Showing results (251-260 of 411) with videos related to

Sort By:
Pageof 42
RNA (New York, N.Y.)|June 17, 2026
A mutation in the nuclear speckle and splicing factor SRRM2 is associated with multisystem proteinopathy and causes dysregulation of synapse-associated genesQingyu Shi, Chloe Lauder, Jolie Marie Miller, et al.
Neurology. Clinical Practice|September 3, 2021
Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study DesignJames Berry, Benjamin Brooks, Angela Genge, et al.
Acta Neuropathologica Communications|July 4, 2020
Quantitative patterns of motor cortex proteinopathy across ALS genotypesMatthew Nolan, Connor Scott, Menuka Pallebage Gamarallage, et al.
Experimental Neurology|January 10, 2016
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cellsRustam Esanov, Kinsley C Belle, Marka van Blitterswijk, et al.
Neurology|April 19, 2023
Addressing Outcome Measure Variability in Myasthenia Gravis Clinical TrialsJeffrey T Guptill, Michael Benatar, Volkan Granit, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 19, 2022
Comparison Of King's Clinical Staging In Multinational Amyotrophic Lateral Sclerosis CohortsRubika Balendra, Ashley R Jones, Ahmad Al Khleifat, et al.
JMIR Mhealth and Uhealth|December 21, 2019
Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational StudyLuis Garcia-Gancedo, Madeline L Kelly, Arseniy Lavrov, et al.
Journal of Lipid Research|November 5, 2016
Defective cholesterol metabolism in amyotrophic lateral sclerosisJonas Abdel-Khalik, Eylan Yutuc, Peter J Crick, et al.
Frontiers in Neurology|April 12, 2019
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral SclerosisPaul Lingor, Markus Weber, William Camu, et al.
Neurology|July 28, 2025
Proposed Research Criteria for Mild Motor Impairment as a Prodromal Syndrome in Amyotrophic Lateral SclerosisMichael Benatar, Xueya Cai, Michael P McDermott, et al.
Pageof 42